PTC Therapeutics
PTCT
#3019
Rank
$5.51 B
Marketcap
$66.06
Share price
-1.94%
Change (1 day)
8.37%
Change (1 year)

PTC Therapeutics (PTCT) Fails to deliver data

Key failure to deliver metrics for PTC Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for PTC Therapeutics (PTCT) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for PTC Therapeutics (PTCT) - since 2013

Volume in USD (price x number of shares), data since 2013

PTC Therapeutics (PTCT) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026$52.55 M26.29%
2025$41.61 M684.69%
2024$5.3 M-52.79%
2023$11.23 M151.98%
2022$4.45 M-68.48%
2021$14.14 M-78.73%
2020$66.49 M326.35%
2019$15.59 M24.24%
2018$12.55 M-45.49%
2017$23.02 M-35.09%
2016$35.47 M-36.68%
2015$56.02 M154.23%
2014$22.03 M233.35%
2013$6.61 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Novartis
NVS
$36.12 M$0.42 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
$6.23 M$0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
$1.55 M$2.96 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
$5.5 M$22.19 M๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
$0.14 M$1.12 M๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
N/A$36.48 M๐Ÿ‡บ๐Ÿ‡ธ USA